Luo Na, Fu Min, Zhang Yiling, Li Xiaoyu, Zhu Wenjun, Yang Feng, Chen Ziqi, Mei Qi, Peng Xiaohong, Shen Lulu, Zhang Yuanyuan, Li Qianxia, Hu Guangyuan
Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Front Cell Dev Biol. 2022 Jun 24;10:935135. doi: 10.3389/fcell.2022.935135. eCollection 2022.
N6-methylandrostenedione (m6A) methylation plays a very important role in the development of malignant tumors. The immune system is the key point in the progression of tumors, particularly in terms of tumor treatment and drug resistance. Tumor immunotherapy has now become a hot spot and a new approach for tumor treatment. However, as far as the stomach adenocarcinoma (STAD) is concerned, the in-depth research is still a gap in the m6A-associated immune markers. The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases is extremely important for our research, where we obtained gene mutation, gene expression data and relevant clinical information of STAD patients. Firstly, the samples from GEO were used as external validation groups, while the TCGA samples were divided into a training group and an internal validation group randomly. Using the way of Single factor COX-LASSO- and multi-factor Cox to construct the prognostic model. Then, all samples were subjected to cluster analysis to generate high and low expression groups of immune gene. Meanwhile, we also collected the correlation between these types and tumor microenvironment. On this basis, a web version of the dynamic nomogram APP was developed. In addition, we performed microenvironmental correlation, copy number variation and mutation analyses for model genes. The prognostic model for STAD developed here demonstrated a very strong predictive ability. The results of cluster analysis manifested that the immune gene low expression group had lower survival rate and higher degree of immune infiltration. Therefore, the immune gene low expression group was associated with lower survival rates and a higher degree of immune infiltration. Gene set enrichment analysis suggested that the potential mechanism might be related to the activation of immunosuppressive functions and multiple signaling pathways. Correspondingly, the web version of the dynamic nomogram APP produced by the DynNom package has successfully achieved rapid and accurate calculation of patient survival rates. Finally, the multi-omics analysis of model genes further enriched the research content. Interference of RAB19 was confirmed to facilitate migration of STAD cells , while its overexpression inhibited these features. The prognostic model for STAD constructed in this study is accurate and efficient based on multi-omics analysis and experimental validation. Additionally, the results of the correlation analysis between the tumor microenvironment and m6Ascore are the basics of further exploration of the pathophysiological mechanism in STAD.
N6-甲基雄烯二酮(m6A)甲基化在恶性肿瘤的发展中起着非常重要的作用。免疫系统是肿瘤进展的关键点,特别是在肿瘤治疗和耐药性方面。肿瘤免疫疗法现已成为肿瘤治疗的热点和新方法。然而,就胃腺癌(STAD)而言,对m6A相关免疫标志物的深入研究仍是一个空白。癌症基因组图谱(TCGA)和基因表达综合数据库(GEO)对我们的研究极为重要,我们从中获取了STAD患者的基因突变、基因表达数据及相关临床信息。首先,将来自GEO的样本用作外部验证组,而将TCGA样本随机分为训练组和内部验证组。采用单因素COX-LASSO和多因素Cox方法构建预后模型。然后,对所有样本进行聚类分析以生成免疫基因的高表达组和低表达组。同时,我们还收集了这些类型与肿瘤微环境之间的相关性。在此基础上,开发了一个网络版的动态列线图应用程序。此外,我们对模型基因进行了微环境相关性、拷贝数变异和突变分析。这里构建的STAD预后模型显示出很强的预测能力。聚类分析结果表明,免疫基因低表达组的生存率较低且免疫浸润程度较高。因此,免疫基因低表达组与较低的生存率和较高的免疫浸润程度相关。基因集富集分析表明,潜在机制可能与免疫抑制功能和多种信号通路的激活有关。相应地,由DynNom软件包生成的网络版动态列线图应用程序已成功实现对患者生存率的快速准确计算。最后,对模型基因的多组学分析进一步丰富了研究内容。证实RAB19的干扰促进STAD细胞迁移,而其过表达则抑制这些特征。本研究构建的基于多组学分析和实验验证的STAD预后模型准确且高效。此外,肿瘤微环境与m6A评分之间的相关性分析结果是进一步探索STAD病理生理机制的基础。